Post-treatment tumor immune microenvironment and the dual role of myeloid-derived suppressor cells (MDSCs) in cancer progression and therapeutic resistance | Synapse
March 3, 2026
Post-treatment tumor immune microenvironment and the dual role of myeloid-derived suppressor cells (MDSCs) in cancer progression and therapeutic resistance
Key Points
Tumor microenvironment influences therapeutic resistance, highlighting its critical role.
Myeloid-derived suppressor cells exhibit both supportive and suppressive effects on cancer progression.
The study utilizes immune profiling to assess post-treatment changes in the tumor microenvironment.
Addressing MDSC dynamics may offer new strategies for enhancing cancer therapy effectiveness.